{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:01:26Z","timestamp":1791478886241,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.anai.2021.08.009","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T18:55:04Z","timestamp":1628880904000},"page":"638-647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Clinical relevance of inherited genetic differences in human tryptases"],"prefix":"10.1016","volume":"127","author":[{"given":"Sarah C.","family":"Glover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody C.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Koro\u0161ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Bonadonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence B.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Milner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George H.","family":"Caughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean D.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2346-8189","authenticated-orcid":false,"given":"Jonathan J.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.anai.2021.08.009_bib0001","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anai.2021.08.009_bib0002","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2018.01.034","article-title":"Mast cells signal their importance in health and disease","volume":"142","author":"Olivera","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2021.08.009_bib0003","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1073\/pnas.83.12.4464","article-title":"Two types of human mast cells that have distinct neutral protease compositions","volume":"83","author":"Irani","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.anai.2021.08.009_bib0004","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaci.2005.02.022","article-title":"Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell","volume":"115","author":"Oskeritzian","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2021.08.009_bib0005","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaci.2016.04.051","article-title":"Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases","volume":"138","author":"Subramanian","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2021.08.009_bib0006","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1742-4658.2006.05211.x","article-title":"Biology of mast cell tryptase. An inflammatory mediator","volume":"273","author":"Hallgren","year":"2006","journal-title":"FEBS Journal"},{"issue":"22","key":"10.1016\/j.anai.2021.08.009_bib0007","doi-asserted-by":"crossref","first-page":"11939","DOI":"10.1016\/S0021-9258(19)68496-6","article-title":"Tryptase from human pulmonary mast cells. Purification and characterization","volume":"256","author":"Schwartz","year":"1981","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.anai.2021.08.009_bib0008","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1047-8477(02)00007-2","article-title":"Colocalization of heparin and histamine in the intracellular granules of test cells from the invertebrate Styela plicata (Chordata-Tunicata)","volume":"137","author":"Cavalcante","year":"2002","journal-title":"J Struct Biol"},{"key":"10.1016\/j.anai.2021.08.009_bib0009","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4939-1568-2_2","article-title":"The phylogenetic profile of mast cells","volume":"1220","author":"Crivellato","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"9","key":"10.1016\/j.anai.2021.08.009_bib0010","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.4049\/jimmunol.179.9.6072","article-title":"Mast cell alpha and beta tryptases changed rapidly during primate speciation and evolved from gamma-like transmembrane peptidases in ancestral vertebrates","volume":"179","author":"Trivedi","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.anai.2021.08.009_bib0011","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"10.1016\/j.anai.2021.08.009_bib0012","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2009.07.026","article-title":"Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations","volume":"124","author":"Trivedi","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2021.08.009_bib0013","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased alpha-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2021.08.009_bib0014","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.anai.2021.08.009_bib0015","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","article-title":"Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression","volume":"8","author":"Robey","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2021.08.009_bib0016","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/ACI.0000000000000678","article-title":"Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia","volume":"20","author":"O'Connell","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2021.08.009_bib0017","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11882-021-01010-1","article-title":"Hereditary alpha-tryptasemia: a commonly inherited modifier of anaphylaxis","volume":"21","author":"Wu","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.anai.2021.08.009_bib0018","doi-asserted-by":"crossref","unstructured":"Konnikova L, Robinson TO, Owings AH, et\u00a0al. Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia [e-pub ahead of print]. J Allergy Clin Immunol. doi:10.1016\/j.jaci.2021.04.004, accessed April 15, 2021.","DOI":"10.1016\/j.jaci.2021.04.004"},{"issue":"10","key":"10.1016\/j.anai.2021.08.009_bib0019","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1084\/jem.20190701","article-title":"Impact of naturally forming human alpha\/beta-tryptase heterotetramers in the pathogenesis of hereditary alpha-tryptasemia","volume":"216","author":"Le","year":"2019","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.anai.2021.08.009_bib0020","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jaci.2006.02.026","article-title":"Tryptase genetics and anaphylaxis","volume":"117","author":"Caughey","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2021.08.009_bib0021","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3389\/fimmu.2017.01749","article-title":"Tracing the origins of IgE, mast cells, and allergies by studies of wild animals","volume":"8","author":"Hellman","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2021.08.009_bib0022","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-065X.2007.00525.x","article-title":"Protease-proteoglycan complexes of mouse and human mast cells and importance of their beta-tryptase-heparin complexes in inflammation and innate immunity","volume":"217","author":"Stevens","year":"2007","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.anai.2021.08.009_bib0023","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbrc.2014.07.124","article-title":"Ancient origin of mast cells","volume":"451","author":"Wong","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.anai.2021.08.009_bib0024","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.abb.2004.12.025","article-title":"Mastin is a gelatinolytic mast cell peptidase resembling a mini-proteasome","volume":"435","author":"Raymond","year":"2005","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.anai.2021.08.009_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pep.2006.04.018","article-title":"Expression and characterization of recombinant gamma-tryptase","volume":"49","author":"Yuan","year":"2006","journal-title":"Protein Expr Purif"},{"issue":"8","key":"10.1016\/j.anai.2021.08.009_bib0026","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/hmg\/9.8.1239","article-title":"Crossover breakpoint mapping identifies a subtelomeric hotspot for male meiotic recombination","volume":"9","author":"Badge","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"7020","key":"10.1016\/j.anai.2021.08.009_bib0027","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nature03187","article-title":"The sequence and analysis of duplication-rich human chromosome 16","volume":"432","author":"Martin","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.anai.2021.08.009_bib0028","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.coi.2021.04.001","article-title":"Mast cell tryptases in allergic inflammation and immediate hypersensitivity","volume":"72","author":"Lyons","year":"2021","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2021.08.009_bib0029","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.jaip.2021.03.005","article-title":"The genetic basis and clinical impact of hereditary alpha-tryptasemia","volume":"9","author":"Luskin","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.anai.2021.08.009_bib0030","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.anai.2021.08.009_bib0031","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.anai.2021.01.016","article-title":"Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis","volume":"126","author":"Giannetti","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2021.08.009_bib0032","doi-asserted-by":"crossref","unstructured":"Chollet MB, Akin C. Hereditary alpha tryptasemia is not associated with specific clinical phenotypes [e-pub ahead of print]. J Allergy Clin Immunol. doi:10.1016\/j.jaci.2021.06.017, accessed June 22, 2021.","DOI":"10.1016\/j.jaci.2021.06.017"},{"issue":"21","key":"10.1016\/j.anai.2021.08.009_bib0033","article-title":"On the complexities of tryptase genetics and impacts on clinical phenotypes","volume":"374","author":"Lyons","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2021.08.009_bib0034","series-title":"Clinical Approach to a Patient With Elevated Serum Tryptase: Implications of Acute versus Basally Elevated Levels","author":"Lyons","year":"2020"},{"issue":"7","key":"10.1016\/j.anai.2021.08.009_bib0035","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMoa1500611","article-title":"Vibratory urticaria associated with a missense variant in ADGRE2","volume":"374","author":"Boyden","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.anai.2021.08.009_bib0036","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jaci.2013.11.039","article-title":"Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities","volume":"133","author":"Lyons","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2021.08.009_bib0037","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10875-018-0506-y","article-title":"First identification of an inherited TPSAB1 quintuplication in a patient with clonal mast cell disease","volume":"38","author":"Sabato","year":"2018","journal-title":"J Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2021.08.009_bib0038","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/PAS.0000000000001676","article-title":"Distinct small intestine mast cell histologic changes in patients with hereditary alpha-tryptasemia and mast cell activation syndrome","volume":"45","author":"Hamilton","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anai.2021.08.009_bib0039","doi-asserted-by":"crossref","unstructured":"Lyons JJ. Inherited and acquired determinants of serum tryptase levels in humans [e-pub ahead of print]. Ann Allergy Asthma Immunol. doi:10.1016\/j.anai.2021.06.019, accessed June 24, 2021.","DOI":"10.1016\/j.anai.2021.06.019"},{"issue":"4","key":"10.1016\/j.anai.2021.08.009_bib0040","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jaci.2020.11.017","article-title":"Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology","volume":"147","author":"Giannetti","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2021.08.009_bib0041","article-title":"Revised diagnostic criteria and classification of mast cell disorders: a consensus proposal","author":"Valent","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anai.2021.08.009_bib0042","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2021.02.043","article-title":"Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone","volume":"148","author":"\u0160elb","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2021.08.009_bib0043","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2021.08.009_bib0044","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2014.11.035","article-title":"Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels","volume":"136","author":"Zanotti","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2021.08.009_bib0045","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaip.2019.01.006","article-title":"Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome","volume":"7","author":"Valent","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2021.08.009_bib0046","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","article-title":"A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis","volume":"141","author":"Carter","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2021.08.009_bib0047","first-page":"89","article-title":"The so-called \u201cidiopathic\u201d anaphylaxis: allergic and pseudo-allergic reactions","volume":"23","author":"Moneret-Vautrin","year":"1991","journal-title":"Allerg Immunol (Paris)"},{"issue":"1","key":"10.1016\/j.anai.2021.08.009_bib0048","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1081-1206(10)61367-1","article-title":"Anaphylaxis: a review of 601 cases","volume":"97","author":"Webb","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.anai.2021.08.009_bib0049","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/adc.88.7.587","article-title":"Therapeutic implications of sex differences in asthma and atopy","volume":"88","author":"Osman","year":"2003","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.anai.2021.08.009_bib0050","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaci.2014.11.003","article-title":"Estrogen increases the severity of anaphylaxis in female mice through enhanced endothelial nitric oxide synthase expression and nitric oxide production","volume":"135","author":"Hox","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2021.08.009_bib0051","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.aller.2014.05.002","article-title":"Clinical characteristics and risk profile of patients with elevated baseline serum tryptase","volume":"42","author":"Fellinger","year":"2014","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"4","key":"10.1016\/j.anai.2021.08.009_bib0052","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1084\/jem.20172306","article-title":"Primary atopic disorders","volume":"215","author":"Lyons","year":"2018","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.anai.2021.08.009_bib0053","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/cea.13485","article-title":"Differential associations of allergic disease genetic variants with developmental profiles of eczema, wheeze and rhinitis","volume":"49","author":"Clark","year":"2019","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.anai.2021.08.009_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125273","article-title":"Association between variants in atopy-related immunologic candidate genes and pancreatic cancer risk","volume":"10","author":"Cotterchio","year":"2015","journal-title":"PLOS ONE"},{"issue":"11","key":"10.1016\/j.anai.2021.08.009_bib0055","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/nu10111582","article-title":"Higher polygenetic predisposition for asthma in cow's milk allergic children","volume":"10","author":"Jansen","year":"2018","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.anai.2021.08.009_bib0056","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jaci.2019.02.016","article-title":"The MALT1 locus and peanut avoidance in the risk for peanut allergy","volume":"143","author":"Winters","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2021.08.009_bib0057","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaip.2019.02.002","article-title":"Mast cell activation syndrome and mastocytosis: initial treatment options and long-term management","volume":"7","author":"Castells","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2021.08.009_bib0058","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpsychires.2020.10.032","article-title":"Misuse and dependence of dimenhydrinate: a mixed studies systematic review","volume":"136","author":"Bahji","year":"2021","journal-title":"J Psychiatr Res"},{"issue":"5","key":"10.1016\/j.anai.2021.08.009_bib0059","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2165\/00002018-199410050-00002","article-title":"H1 receptor antagonists. Comparative tolerability and safety","volume":"10","author":"Simons","year":"1994","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.anai.2021.08.009_bib0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/0269881107083809","article-title":"Diphenhydramine abuse and detoxification: a brief review and case report","volume":"23","author":"Thomas","year":"2009","journal-title":"J Psychopharmacol"},{"issue":"6","key":"10.1016\/j.anai.2021.08.009_bib0061","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s10072-021-05043-2","article-title":"Antihistamines as a common cause of new-onset seizures: a single-center observational study","volume":"42","author":"Kim","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.anai.2021.08.009_bib0062","doi-asserted-by":"crossref","first-page":"j1415","DOI":"10.1136\/bmj.j1415","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study","volume":"357","author":"Waljee","year":"2017","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.anai.2021.08.009_bib0063","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bjo.82.6.704","article-title":"Systemic corticosteroid therapy\u2014side effects and their management","volume":"82","author":"Stanbury","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.anai.2021.08.009_bib0064","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2019.09.026","article-title":"Clinical response to omalizumab in patients with hereditary alpha-tryptasemia","volume":"124","author":"Mendoza Alvarez","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2021.08.009_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.11.005","article-title":"A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis","volume":"147","author":"Carter","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2021.08.009_bib0066","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5785378","article-title":"Hypertryptasemia and mast cell-related disorders in severe osteoporotic patients","volume":"2020","author":"Carosi","year":"2020","journal-title":"Mediators Inflamm"},{"issue":"12","key":"10.1016\/j.anai.2021.08.009_bib0067","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: relationship to daily and cumulative doses","volume":"39","author":"van Staa","year":"2000","journal-title":"Rheumatol (Oxf Engl)"},{"issue":"5","key":"10.1016\/j.anai.2021.08.009_bib0068","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5070\/D30FK211ZH","article-title":"Cutaneous mastocytosis: two pediatric cases treated with topical pimecrolimus","volume":"16","author":"Correia","year":"2010","journal-title":"Dermatol Online J"},{"issue":"9","key":"10.1016\/j.anai.2021.08.009_bib0069","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.leukres.2011.05.006","article-title":"Tyrosine kinase inhibitors in the treatment of systemic mastocytosis","volume":"35","author":"Ustun","year":"2011","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.anai.2021.08.009_bib0070","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bjh.13951","article-title":"Beneficial effects of JAK inhibitor therapy in systemic mastocytosis","volume":"176","author":"Dowse","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anai.2021.08.009_bib0071","article-title":"Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis","author":"Mateja","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2021.08.009_bib0072","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2019.09.009","article-title":"An allosteric anti-tryptase antibody for the treatment of mast cell-mediated severe asthma","volume":"179","author":"Maun","year":"2019","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.anai.2021.08.009_bib0073","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.iac.2020.06.007","article-title":"Targeting mast cells with biologics","volume":"40","author":"Lyons","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"issue":"9","key":"10.1016\/j.anai.2021.08.009_bib0074","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1172\/JCI138448","article-title":"Bruton's tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis","volume":"130","author":"Dispenza","year":"2020","journal-title":"J Clin Invest"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621005676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621005676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:27:27Z","timestamp":1761053247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120621005676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1081120621005676"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2021.08.009","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical relevance of inherited genetic differences in human tryptases","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2021.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}